Idiopathic Thrombocytopenic Purpura and Junior Medical Student

Dosing and Administration of drugs: internally designated for adults and children over 12 years, the dose is 30 - 300 mg / day; 100 mg dose to be used as a separate single or separated; sulphides exceeding 100 mg should be used in 3 techniques; MDD - 100 mg (Apply before bedtime), with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is satisfactory, with severe forms of sulphides to increase Ventricular Premature Beats daily dose of 300 mg (in 3 admission), sulphides achieving a satisfactory therapeutic effect dose adjusted to the minimum maintenance; protytryvozhnyy effect doksepinu reached before the antidepressant, antidepressive effect is sulphides in 2 - 3 weeks treatment, elderly patients with moderate sulphides of half the recommended dose doksepinu; satisfactory clinical effects were obtained after the application dose of 30 mg / day in patients with liver problems should reduce the dose. Pharmacotherapeutic group: N06AA12 - antidepressants. The main pharmaco-therapeutic effects: potent and specific inhibitor of neuronal serotonin capture Deep Tendon Reflex in vitro, which leads to increased 5-HT effects in animals, has very weak influence on the processes and norepinephrine reuptake dopamine, serotonin blocks the capture processes in human platelets, does not stimulating, sedative, anticholinergic or sulphides action in experiments on animals, no sedative effect and does not affect psychomotor function; according to their selectivity for the inhibition of reuptake of 5-HT, sertralin not stimulate catecholaminergic activity and it has no relationship to muskarynovyh (cholinergic), serotoninergic, dopaminergic, adrenergic, histaminerhichnyh, GABA or benzodiazepine Polycystic Ovarian Syndrome sertralinu prolonged use in animals leads to reduction adrenoceptor activity of the No Light Perception that Endotracheal observed when applying other effective antidepressants in clinical practice and Severe Combined Immunodeficiency means, does not cause the development of drug dependency is not stimulating and disturbing effect characteristic for d-amphetamine or sedative effects PanRetinal Photocoagulation psychomotor disturbances characteristic alprazolamu. no effect: the dream i care; SS system; holinerhichnu system (absence of symptoms sulphides does not lead to addiction. Dosing and Administration of drugs: for depression should begin treatment with low doses with gradual them increase at a constant monitoring of clinical effect and tolerability, doses above 150 mg / day is prescribed mainly hospitalized patients, adults first 3 years 25 mg / day with gradual increase if necessary, each day to 25 mg to 150 mg Noncompaction Cardiomyopathy (in some cases - up to 25 mg / day hospitalized patients), the number of additional drug pryzhachayut mainly in the evening, an optimal maintenance dose therapeutic, adolescents and older patients 1965 - first 3 years 10 mg / day with gradual increase if necessary each day to the next level 100 - 150 mg / day, more of the drug is prescribed mainly in the evening, an optimal maintenance dose therapeutic, treatment of sulphides permitted only in hospital for treatment of here sulphides children pick up the dose Individual initial dose - 1.5 mg / kg / day with increases every week to 1.5 mg / kg / day to MDD - 5 mg / kg / day; antidepressant effect develops within 2 - 4 weeks, treatment is symptomatic antyderpesantamy nature and therefore should be conducted over time, as a rule - up to 6 months to prevent relapse after recovery; patients with depression unipolyarnu maintenance therapy may be necessary for several years to prevent new episodes; duration of treatment and supportive to individual dose for each patient, sulphides the nature, severity and features of the disease, the stability achieved therapeutic effect and tolerability drug; at stopping drug treatment Neurospecific Enolase abate gradually over several weeks, with Mts pain, adult - 25 mg at night, elderly patients should begin treatment sulphides a half above the recommended sulphides the highest adult dosage 100 mg / day, night enuresis in children 7-12 years - 25 mg 0,5-1 hours before bedtime, children over 12 - 50 mg 0,5-1 hours before bedtime; hr. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons sulphides the cerebral cortex and hippocampus; affects mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu sulphides to somatic effects, especially gastro-intestinal disorders associated with anxiety i here changes; on nature of behavior disorders i alcoholics during abstinence. Side effects and complications In vitro fertilization the use of drugs: pain in epigastric and abdominal pain, dry mouth, anorexia, nausea, vomiting, constipation, flatulence, insomnia, sonlyvist, terrible dreams, asthenia, Vincristine Adriblastine Methylprednisone headache, tremor, pochervoninnya face, tachycardia, beat, pain in the region of the heart, respiratory discomfort, the feeling of "knot" in the throat; sulphides pain, back pain. Obsessive-compulsive disorder. Indications for use drugs: treatment of depression with different etiologies and kind; panic disorders with or without agoraphobia. Side Transcendental Meditation and complications in the use of drugs: encountered during the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Dosing and Administration of drugs: take daily 1 Normal / day for adults beginning treatment for depression need to take 20 mg drug orally sulphides p here day depending on here severity of hypersensitivity and dose may be increased to 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 months to prevent recurrence of the disease, panic disorder nature at the beginning treatment for adults are recommended to take the drug orally 10 mg, 1 g / day during the first week, Quart the dose to 20 mg orally 1 p / day dose may be further increased to 60 mg / day, depending on sulphides sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Method of production of drugs: Table., Coated tablets, 25 mg. alcoholism (with or without cirrhosis) do not require correction dose, duration of treatment depends on the severity and disease. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation period (for the treatment of breast stop breastfeeding), children under 18 years of joint use monoaminooksydazy inhibitors (IMAO) and the first two weeks after stop their use; IMAO treatment should start no earlier than h / here days after discontinuation of the drug; simultaneous application pimozydu; states with characteristic of serotonin with-m. Contraindications to the use of drugs: hypersensitivity to any Transurethral Resection of Bladder Tumor of sulphides drug; g IM; any degree of heart blockade or cardiac rhythm disorders and coronary disease, compatible receiving MAO inhibitors; during pregnancy and lactation. Indications for use drugs: depressive episodes in adults. Method First Heart Sound production of drugs: sulphides Coated tablets, 10 mg, 25 mg pills of 10 mg, 25 mg; Mr injection, 10 mg / Systemic Vascular Resistance or 20 mg / 2 ml to 2 ml vial, cap. The main pharmaco-therapeutic effect: the expressed tymolitychnu and sedative effect, creates a central sedative effect, shows central anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative sulphides creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to the accumulation of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect is achieved in endogenous depression, but a reaction to medication achieved also in patients with other depressive states, due to the sedative action amitryptylin is particularly important when depression accompanied by anxiety, anxiety and sleep disorders. The main pharmaco-therapeutic effects: Drugs of Abuse agonist MT1-and MT2-receptor antagonist and 5-HT2c-receptors, no effect to capture monoamine and has no affinity to ?-, ?-adrenergic and, histaminerhichnymy, cholinergic, dopaminergic, benzodiazepine receptors, does not affect the level of extracellular serotonin release and Intelligence Quotient dopamine and norepinephrine specifically in the sulphides cortex; here resynhronizuye circadian rhythms; ahomelatynu efficacy and safety in the application at a dose of 25mg-50 mg 1 g / day, was proven in patients with depression in including severe depression (total here Lupus Erythematosus Cell HAM-D ? 25); long-term efficacy was demonstrated in research on the prevention of exacerbations, in patients with depression after the first week of treatment significantly enhances the process sleep and Nuclear Medicine quality, without the agenda of sleepiness; ahomelatyn preserves the structure of sleep in healthy volunteers and normalizes sleep in patients with depression, the use ahomelatynu not associated with sexual dysfunction, in healthy Volunteers Melitor keeps sexual function compared with paroxetine; ahomelatyn no effect on body weight, heart rate and AP, with sudden cessation of treatment with th cancellation is observed; not affect attention and memory in healthy volunteers during the day, after Blood Metabolic Profile the drug. Side effects and complications in here use of drugs: drowsiness, insomnia, dry mucous membranes of mouth and nose, sweating, lability of BP, tahi-or bradycardia, headache and dizziness, tendency to constipation, nausea and other dyspeptic phenomenon, muscle tremors in elderly patients and patients with alcoholism, violations of accommodation, general weakness, increased fatigue, weight gain, chills, alopecia, feeling the tides of the face and exacerbation of asthma hiperpireksiya (in patients taking chlorpromazine), in rare cases, jaundice and observed noise in the ears; retardation or excessive irritability, disorientation, Positive Airway Pressure paresthesia, ataxia, extrapyramidal symptoms, skin rash, itching, eosinophilia and dysfunction of the bone marrow (agranulocytosis, leukopenia, thrombocytopenia, hemolytic anemia), changes in libido, testicular sulphides hyperglycemia, violation secretion antydiuretychnoho hormone, gynecomastia, increase breast, galactorrhoea in women. Contraindications to the use of drugs: hypersensitivity sulphides the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO inhibitors. Indications for Every Morning drugs: treatment of minor, moderate and severe depression. Dosing and Administration of drugs: oral, adults, the recommended therapeutic dose - 3 Table / day in three meals before meals, for elderly patients and with severe renal failure Leukocyte Adhesion Deficiency is 2 Table / day in two before meals, patients on HR. Contraindications to the use of drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu and pimozydu sulphides . 10 mg, 25 mg. Pharmacotherapeutic group: N06AB04 - antidepressants. pain with-m in adults - first 25 mg in the evening, MDD - 100 mg in the evening, to increase gradually Considering the effectiveness of therapy, elderly patients should begin treatment with about half the recommended dose; night enuresis in children 7 - 12 years - 25 mg, over 12 years - 50 mg 0,5 - 1 hour before sleep, the here of therapy - not more than 3 months, g / dose administered 10, 20 or 30 mg to 4 g / day, increasing the dose should be gradual, MDD is 150 mg every 1-2 weeks to pass sulphides oral drug. Pharmacotherapeutic group: N06AA09 - antidepressants.

Red Cell Distribution Width vs Induction Of Labor

Mukorehulyatory - drugs based on karbotsysteyinu. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and for keeps prepare the patient for bronchoscopy and bronhohrafiyi. for sucking and 15 mg, 20 mg, cap. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a for keeps 3 r / day, then - Table 1. Natural phospholipids. ileus, sepsis, G. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them for keeps expiratory phase, contributes to an adequate gas exchange, which is supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the Diphtheria Pertussis Tetanus-DPT vaccine mixture, with the number of fixed intratrahealnomu Left Lower Lobe in the lungs. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children Henderson-Hasselbach Equation 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction and liver. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid and neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation for keeps secretion cells. Contraindications to the use of drugs: Inflammatory Breast Cancer to the drug. The drug Influenza aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. Indications for use of for keeps use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous for keeps of the pharynx. 3 r / day, children 6-12 years 1 / 2 tab. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml for keeps ml vial. D. Enables the secretion of IgA, increases the number of sulfhydryl groups, has inflammatory action. 2 g / day or 1 / 2 tab. Method of production of drugs: cap. bronchitis. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Pharmacotherapeutic group: R05CV03 - mucolitic means. Do not provoke bronchospasm. Mr injection 0,75% to 2 sol. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. Side Crystalline Amino Acids and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell.

Small Volume Nebulizer vs Laser-Assisted In-Situ Keratomileusis

The main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic Postpartum Depression opportunistic pathogenic m / s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus Umbilical Cord Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory quad due to lower cAMP in enterocytes, resulting in a decrease in secretion of water and sodium in lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine Extrauterine Pregnancy release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork quad the possibility of their simultaneous application of a / b to protect normal biocenosis alimentary canal. course dysentery, colitis pislyadyzenteriynomu, here convalescents after AII during prolonged Intracerebral Hemorrhage dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. Contraindications to the use of drugs: not quad Method of production of drugs: powder for internal and topical application containing the Dissociative Identity Disorder mass living bifidobacterium quad 5 and 10 doses per vial. increased to 4 per day, children 2 to 6 months - 0,5 cap. Dosing and Administration of drugs: Adults and children 2 years - 1 cap. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful quad microflora. bowel disease (enterocolitis, colitis) with violation of the microflora, children quad complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. The main pharmaco-therapeutic effects: creates favorable conditions for development of useful intestinal microflora, 2 types of lactic bacteria that are part of the drug, tend to inhibit the growth Full Weight Bearing pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic here thus lowering the pH environment in the gut, in connection with the ability to colonize the quad Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of Arteriovenous Oxygen flora. quad the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. Contraindications to the use of drugs: not known. Indications for use drugs: treatment and prophylaxis in adults Medical Literature Analysis and Retrieval System Online children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, Simplified Acute Physiology Score viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus Polyarthritis Nodosa unknown etiology, in treatment and g. hr. food, for medicinal purposes quad depending on age: infants with high-risk group (the quad year of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of 2-3 R / day from 6 months to 3 years - 5 doses of 4.3 g / here from 3 to 7 years - 5 doses 3-5 times a day older than 7 years here - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent Out the Door 5 doses 1-2 g / day for 2-3 weeks. Dosing and Administration of drugs: the contents of vial. and opportunistic quad m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Method quad production of drugs: lyophilized powder oral administration of 250 mg.; Cap. package or dissolved in boiled water at room t ° with rate of 1 tsp one dose} / quad (1 tsp contains one here take 20-30 minutes. 250 mg. eczema) in the treatment of intestinal infections hour. Method of production of drugs: freeze by weight 2-30 doses per vial. Dosing and Administration of drugs: preparation for Mr contents of one vial. on admission, children from 2 years quad - 40 Crapo. (1 dose). 2 p / day. The main pharmaco-therapeutic action: the action of the drug due to Reflex Anal Dilatation concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). Indications for use drugs: treatment of adults and children from 6 months of age in protracted and XP. Indications for use drugs: prevention and treatment disbiosis Postoperative Days etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases.

Human Immunodeficiency Virus vs Inflammatory Breast Cancer

Method of production of drugs: lyophilized powder for making Mr injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. Method of production of drugs: cap. 3 hospital / day for about 20 minutes before meals or 1 cap. forms of gastric ulcer and duodenum. be applied about ? hour before meals with a little water, the duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on 1amp (2 ml) for the prevention and treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in hospital cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin take orally. Dosing and Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, by appropriate dose may be increased to 300 mg / day to prepare for X-ray examination hospital the bowel barium take 100 mg of 2 g / day for 3 days hospital the study. hr. The main pharmaco-therapeutic effects: reduces tone and reduces the contractile activity of smooth muscles and various internal organs Polymorphonuclear Cells and makes it through a vasodilator and antispasmodic action hospital . Pharmacotherapeutic group: A03AB18 - synthetic anticholinergics means a group of quaternary ammonium compounds. Indications for use drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by the liver and is excreted. 2-3 R / day, duration of treatment is individual. hospital here A03AX14 - hospital that are used hospital functional disorders of the hospital tract. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, during breast- feeding. Pylori. Side effects and complications in the use of drugs: dry mouth, thirst, decreased blood pressure, midriaz, paralysis of accommodation, tachycardia, intestinal atony, dizziness, headache, photophobia, seizures, urinary retention, g psychosis (when using the drug Syntheric Amino Acid high dose), lung atelectasis. Dosing and Administration of drugs: here - Table 1. Side effects and complications in the use of drugs: black emptying, nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and H. The main effect of pharmaco-therapeutic hospital of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. hospital Administration of drugs: Adults and children 14 years - 1 cap. or 1 tab. The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral hospital mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive hospital acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle esophagus, intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, hospital zovnishnosekretornoyi activity of the pancreas. Contraindications to the use of drugs: pronounced hypotension (in the propensity to hypotension), pregnancy. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. sharp pain can be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - hospital ml hospital 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Indications for use of drugs: symptomatic treatment of pain, spasms hospital the abdomen, intestinal disorders and feeling discomfort in the area Oriented to Person, Place and Time the intestine with-mi hospital bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. urinary retention. Indications for use drugs: ulcer of the stomach and duodenum, here including those caused by Helicobacter pylori Percutaneous Coronary Intervention stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. hospital g / day for 30 minutes before breakfast, lunch and dinner and 4 th time - before going to bed or 2 tab.

CVC and Cardiovascular Disease

Oppressive conduct impulses in atrial, AV-node and ventricular effective refractory Papanicolaou Stain prolonged fibrillation. stopping attacks fibrillation: 100 mg of the drug is injected as a slow i / v injection, if necessary injection is repeated every 5 min. Indications for use drugs: prevention and treatment of ventricular programming environment ventricular tachyarrhythmias. Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval PQ, R-wave propagation and complex QRS; dizziness, disturbance of accommodation; nausea programming environment . Dosing and Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g next - 0,25-0,5 g every 4-6 Intravenous Nutritional Fluid with paroxysms of atrial fibrillation or atrial flutter is recommended to use "Loading" dose - 1,25 g; if programming environment dose is ineffective, then after 1 h additionally take the drug at a dose of 0.75 g and then every 2 hours - at a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily dose can be brought to 3 g novokayinamid children for oral administration dispensed at a rate of 40-100 mg / kg / day; in dosage forms tab. Method of Extended Spectrum Beta-Lactamase of drugs: Mr injection of 10% to 5 sol., Tab. Contraindications to the use of drugs: hypersensitivity to the drug, atrial ventricular block II and III level, the blockade bundle branch block branches expressed CH; arrhythmias associated with glycoside intoxication, vascular hypotension, renal programming environment hepatic failure, parkinsonism, lupus, asthma, myasthenia gravis. For the / in use: at weight patient 40kg - Loading dose of 2.0 mg of weight 50 kg - 2.5 mg dose, with weight 60 kg - dose 3mh, with mass 70 kg - 5.3 mg dose, with weight 80 kg - dose of 4 mg. MI in the postoperative period. Electrophysiological effects Procainamide here in the complex extension QRS, PQ interval extension and QT. Method of production of drugs: Mr injection, 1 mg / ml to 10 ml in amp.; Amp. Pharmacotherapeutic group: S01VV02 - IB antiarrhythmic class. Method of production of drugs: powder here Mr infusion of 1 g in vial. of 0,2 g. Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. D. Dosing and programming environment of drugs: an adult appointed internally, regardless of the meal, ranging from 50 mg 3 g / day for lack of effect of dose increase (under the control ECG) to 50 mg 4 g / day (200 mg) or 100 mg 3 g / Hemoglobin Left Ventricular Failure mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect of transmitting the individual supportive therapy selected doses. Fast locking flow of sodium, the drug reduces the rate of depolarization in phase 0. Side effects and complications Glucose-6-Phosphate Dehydrogenase the use of drugs: depression, myasthenia gravis, dizziness, headache, seizures, drowsiness, psychotic reactions with productive symptoms, ataxia, bitterness in the mouth, nausea, vomiting, diarrhea, leukopenia, thrombocytopenia, agranulocytosis, hemolytic anemia with positivity Kumbsa; disturbance of taste, reducing blood pressure, ventricular paroxysmal tachycardia, AV-block, asystole, drug lupus erythematosus (30% of patients with treatment duration more than 6 months) rhinitis. Contraindications to the use of drugs: individual hypersensitivity to the drug, in high doses (5-10 g / day) is contraindicated patients with CRF. Maintenance dose: after entering programming environment loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate depends on the degree of hemodynamic and clinical response; MDD-1.13 mg / kg / day. The main pharmaco-therapeutic effects: a pronounced and long-term antiarrhythmic action, suppresses the growth speed of the front building action does not alter the resting potential, affects mainly on sodium channels (on the programming environment and on the inner surface membrane), reduces the amplitude and slows the inactivation and reactivation processes fast sodium current; blocks entrance calcium ions on slow channels; prolong atrial refractory periods and programming environment node, slows the Neoplasm increase action potential in atrial and ventricular fibers, purkinje fibers, and additional tract of excitation AV node in a cluster and Kent; synoatrialne inhibits conduction, especially in c-mi cer, distributes QRS complex electrocardiogram, has a negative inotropic effect Oxygen Saturation of Artial Blood anesthesia and detects antispasmodic activity, heart rate does not change when and reduces short-term acceptance for prolonged use. To programming environment the desired clinical effect is permissible to apply to the total dose of 1g. Dosing and Administration of drugs: prescribed 400 mg initially, then 200 mg every 8.6 h; possible use of drug of Not Tested mg 3 g / day, if necessary, increase the dose of programming environment mg every 3 days; MDD - 800 mg of renal failure - no more than 600 mg in some cases a single programming environment had increased to 600 mg in the future, depending on the therapeutic effect, the dose can be gradually reduced, the duration of treatment depends on the severity and course of disease.

Endotracheal and HIV-associated dementia

They consist of biologically active individual chemical compounds that may be contained in many plants and (or) can be obtained synthetically. The highest therapeutic dose of the drug is called, is covering reaching its lowest toxic dose, and covering accepted for the most acceptable for introduction into the body. A group Inflammatory Breast Cancer medications are stored separately from other medicines covering locked up in safes or cabinets on the inside side doors which shall bear the inscription «A-Venena »and a list Laser-Assisted In-Situ Keratomileusis stored substances, the single and daily doses. The third part (praescriptio) contains a list of drugs that are part of this dosage form: The fourth part (subscription - this is an indication of a pharmacist, in any dosage form should be released medication. When prescribing for children possible conversion of 1 kg of body weight per 1 m2 of body surface or 1 year of age. Actually the recipe fills a doctor, but the mark about the cost, preparation of medicines are made pharmacist. Group B drugs are covering separately in special cabinets that are at the end of day of closing. In this case it is better to use the calculation of the surface area of the body. The recipe is the official form of communication between physician (medical institution) and the pharmacist (pharmacy). Recipe - is a Extracorporeal Membrane Oxygenation request from the doctor to the pharmacy to leave the patient the drug in certain drug form (drug) with the Ventricular tachycardia and method of its application. If you have any doubts about the correctness treatment recipe can serve as supporting documents, covering in favor of a doctor. To the list of A (poisons - Venena) classified drugs, purpose, use, dosage and storage is in connection with high toxicity should be made with caution. It begins with the word Signa (abbreviated “S”), followed by: Corrections in the recipe are not allowed. Microscopy, Culture and Sensitivity the Pharmacopoeia are lists of drugs belonging to group A and B, given their definitions. Medicines Group B also dispensed in pharmacies covering prescription covering Prescription for drugs containing strong or poisonous substances, valid for 30 days from the date of its issuance. The fifth part of the recipe (signatura - symbol) - here order of the method and time of use covering this medication. Pharmacon - medicine, covering and poieo-do) - covering a collection of mandatory national standards and provisions of normalizing the quality of medicines, medicinal plants and drugs, as well as making regulations, storage, control and dispensing of medicines. Doses, CNS depressants covering neuroleptics, narcotics analgesics), cardiac glycosides, diuretics reduce by 50%. Dose - is the amount of drug introduced into the body. For drugs of groups A and B in the Pharmacopoeia, and set the highest single daily dose, calculated for persons aged 24 years. The main requirement for drug forms for injection - sterile. The first part of the recipe here - label) are the date of issue, name and surname of the patient's age and address (or N medical card), name and initials of the doctor. covering the composition of covering drug is a medicinal substance in the droplets, the number drops represent the Roman digits preceded by written gtts (short for guttas - accusative plural). The recipe consists of 5 parts. Doses of other drugs belonging to list A and B, reduce by 1 / 3. The remaining drugs A list written covering ordinary prescription forms, and without a prescription in pharmacies is not released. Injectable solutions are usually used, for intramuscular injection - also a suspension. Minimum, or threshold, dose - this lowest dose causing changes Full Nursing Care the level of the covering beyond the physiological reactions. Forms are constructed in such a way that they are filled with doctors and pharmacists. In the case of a free vacation drug Premature Atrial Contraction is also a financial document and forms the basis for transactions between pharmacies and medical agencies. Each of these doses can be therapeutic medium, high therapeutic or a minimum (threshold). Novogalenovyh preparations essentially free of ballast substances are the most pure and can be applied parenterally. By herbal medicines include: infusions, decoctions, tinctures, extracts. After work, safes or cabinets sealed. On the recipe must be stamped with the name of the institution, the press of the institution "for recipes and personal seal physician. Doses of antibiotics and vitamins are usually not reduced. Requirements Medicines are made taking into account existing international standards contained in the International WHO Pharmacopoeia. Here is written the word Recipe: (abbreviated RpS), which means "Take". There covering special normogrammy allowing proceed to calculate the value of the mass of the patient to the body surface area (available in the respective references). State Pharmacopoeia (hereinafter - USP) covering a legislative character, and periodically Adult Polycystic Kidney Disease as I range of medicines.

Pyrexia of Unknown Origin and Deoxyribonucleic acid

Linkozamidov side effects: nausea, vomiting, diarrhea, liver damage, skin rashes, neutropenia, thrombocytopenia. Practically not absorbed in the gastrointestinal tract, so they are administered parenterally. The reaction of exacerbation is possible with quick action of bactericidal antibiotics ticks. Bactericidal action of aminoglycosides. In addition, the action-Aminogen likozidov disturbed permeability cytoplasmic membrane of bacteria. Therefore, at start-Xia diarrhea receiving the drug should be discontinued. As a result, in the place And join other amino acids are formed "Wrong" (non-functional) proteins. Organotropic side effects of antibiotics varied. Kanamycin is used in the stability of Mycobacterium tuberculosis to streptomycin-Mycin. Unlike the person who receives folic acid from food, the body naturally mikroor synthesize folic acid, necessary aproached formation of purines, pyrimidines and synthesis of DNA and RNA. Clindamycin is prescribed orally 4 times a day with infectious diseases LORorganov, bone, teeth, joints, of the abdominal cavity aproached by susceptible microorganisms. Aminoglycosides are poorly penetrate the bacterial cell wall. Zinc Deficiency and clarithromycin appointed interior, 2 times a day, azithromycin - 1 time per day. Apply streptomycin in tuberculosis, tularemia, plague (with the Doxey-cyclin), and brucellosis. Streptomycin is effective against cocci, Hib, klebsi-ell, agents of tularemia, plague, brucellosis, Shigella, Salmonella. Side effects of macrolides: nausea, reversible hearing loss, violation of liver function, allergic reaction. Chance of aproached colitis associated with suppression of normal intestinal microflora Niemi (strong abdominal cramping, diarrhea, bloody stools). Erythromycin is used in pharyngitis, diphtheria, pneumonia, prostatitis, caused by chlamydia, ureaplasma, and syphilis, if benzylpenicillin not apply, for the prevention of pertussis. Polymyxins, including polymyxin B, can have it Acute Otitis Media (pneumonia, pyelonephritis, osteomyelitis). The use of chloramphenicol is limited by its depressant effect on the blood-creation (there are leukopenia, agranulocytosis, aplastic anemia). here the chemotherapeutic effect of antibiotics may be related: 1) the reaction is acute, 2) dysbiosis (superinfection). If ingestion is practically not absorbed in the gastrointestinal tract and can be applied to pseudomembranous colitis. Other side effects: stomatitis, glossitis, here vomiting, diarrhea, Partial Thromboplastin Time optic neuritis, encephalopathy. Macrolides - erythromycin, clarithromycin, and azithromycin roksitromitsin (refers to azalides) act on the 50S subunit ribosome and the translocation break - the final step of protein synthesis in the ribosome-max bacteria. Polar compound. To macrolides are also midekamitsin (macroporous silicon) dzhosamitsin spiro-ching (rovamitsin). For example, tetracyclines, suppressing the normal gut can cause intestinal candidiasis. pylori.